Prodia Diagnostic Line is trading at IDR 126.00, down 6.67%, amid pressure on Indonesian shares following MSCI’s proposal to reclassify the country from emerging-market to standalone-market status. - The proposal raised concerns about potential foreign investment outflows. - Indonesia’s benchmark index fell more than 5% on October 19 as investors reassessed the risk. - No clear company-specific announcement explaining the move was found; turnover was IDR 31.76 million.